Cargando…
Identification of four key biomarkers and small molecule drugs in nasopharyngeal carcinoma by weighted gene co-expression network analysis
Nasopharyngeal carcinoma (NPC) is a heterogeneous carcinoma whose underlying molecular mechanisms involved in tumor initiation, progression, and migration are largely unclear. The aim of the present study was to identify key biomarkers and small-molecule drugs for screening, diagnosing, and treating...
Autores principales: | Pan, Xi, Liu, Jian-Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806459/ https://www.ncbi.nlm.nih.gov/pubmed/34261404 http://dx.doi.org/10.1080/21655979.2021.1949844 |
Ejemplares similares
-
Identification of novel biomarkers and small-molecule compounds for nasopharyngeal carcinoma with metastasis
por: Mi, Jing-Lin, et al.
Publicado: (2020) -
Identifying key genes and small molecule compounds for nasopharyngeal carcinoma by various bioinformatic analysis
por: Fang, Lucheng, et al.
Publicado: (2021) -
Screening and identification of key biomarkers in nasopharyngeal carcinoma: Evidence from bioinformatic analysis
por: Zhang, Ji-Zhou, et al.
Publicado: (2019) -
Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020) -
Identification of key genes involved in nasopharyngeal carcinoma()
por: Jiang, Xue, et al.
Publicado: (2016)